the insomnia trial produced a statistically significant outcome and zelira now boasts a clinically validated insomnia formulation, maiden revenues, multiple products entering the market and research developments.
the result of 90 million shares being issued today to the share price would of been an expected outcome by the board.
this is a penny stock - highly volatile and todays result shows how disconnected from intrinsic value the share price can be.
every body here looked at the same deliverables and took a punt - the impact of those shares released needs to run its course - people will sell and others will buy - it is what it is.
eventually (and this remains a punt) zelira delivers on what it has announced and the volatility inherant with this end of the stock market flips to the upside.
hold fast or sell or do what you think best - everybody els is.
Ann: Zelira Meets Primary Endpoints for Insomnia Trial, page-97
-
- There are more pages in this discussion • 172 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
0.100(27.8%) |
Mkt cap ! $5.219M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 47.0¢ | 38.0¢ | $5.725K | 13.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1589 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 240 | 1 |
View Market Depth
| Last trade - 15.31pm 05/07/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |